AtaiBeckley
New York · 16 people tracked
Investment thesis
AtaiBeckley is dedicated to advancing a new era of mental health treatment, aiming to deliver not just symptom relief but lasting change for the more than one billion people living with mental health conditions. Its clinical development programs target major unmet needs in depression and social anxiety disorder, where existing therapies often have limited efficacy, slow onset and tolerability challenges. The organization is developing several novel compounds, including BPL-003 (an intranasal mebufotenin benzoate formulation) and VLS-01 (a buccal film DMT formulation) for depression, and EMP-01 (an oral R-MDMA formulation) for social anxiety disorder.
Source: firm website, verified Aug 7, 2026.
Team · 16 people
from the firm's websiteWhat they invest in
from 2 of 7 portfolio companiesHealthtech ×2Biotech ×1Digital Health ×1Medical Devices ×1Mental Health ×1
HQs:United States×1
Investments · 7 tracked
founders shown can be your intro pathCleveland Clinic is a patient-centered academic medical center providing clinical care, research, and medical education.
Digital HealthHealthtechMedical DevicesCleveland, US
ATAI is developing rapid-acting, durable mental health treatments to address unmet needs in psychiatric conditions affecting over one billion people globally.
BiotechHealthtechMental Health
Frequently asked questions
- What sectors does AtaiBeckley focus on?
- AtaiBeckley focuses on Biotech, Healthtech, Mental Health.
- Where is AtaiBeckley located?
- AtaiBeckley is headquartered in New York, US.
- Does AtaiBeckley lead rounds?
- AtaiBeckley typically participates in rounds rather than leading them.
Images
Similar investors
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.
JAZZ Venture Partners is a venture capital firm investing in companies at the intersection of technology, neuroscience, and human performance, spanning digital health, biosciences, and AI.
MedMountain Ventures (MMV) is an early-stage healthcare investment firm founded by board-certified physicians and seasoned healthcare operators, backing companies that improve patient outcomes and reshape how care is delivered, financed, and accessed.
MPM BioImpact is a life sciences investment firm that creates, builds, and invests in biotechnology and healthcare companies developing transformative medicines, spanning both private company creation and public market investing.
Refactor is a seed-stage venture firm run as a solo capitalist by Zal, backing founders building hard tech companies that address real-world problems.